Mainstream

Baxter lowers operational sales growth outlook to 3%-4% for 2025 amid Novum pause and fluid conservation

Baxter lowers operational sales growth outlook to 3%-4% for 2025 amid Novum pause and fluid conservation

Post ContentbaxRead More

You might also be interested in reading US SEC Reportedly Probing Coinbase for Listing Unregistered Securities.

July 31, 2025
In Mainstream